Peringatan Keamanan

There are no data regarding overdose with riltozinameran. In the event of a suspected overdose, monitoring of vital functions and symptomatic treatment is recommended.L45419

Riltozinameran

DB17095

biotech approved investigational

Deskripsi

The Omicron variant of SARS-CoV-2 is a variant of concern that was first reported in November 2021.L43922 It tends to cause less severe disease but is significantly more virulent than both the original virus and earlier variants (e.g. Delta).L43917 As of November 2022, it is the primary circulating variant of concern according to the World Health Organization.L43922 The Omicron variant comprises several distinct lineages and sublineages (e.g. BA.4, BA.5) which, although similar, may behave differently from one another.L43917

Riltozinameran is an mRNA vaccine encoding the S glycoprotein of SARS-CoV-2 Omicron variant lineage BA.1. It is administered in combination with tozinameran for active immunization against COVID-19 caused by SARS-CoV-2, including infection caused by Omicron BA.1L45419

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Contoh Produk & Brand

Produk: 1 • International brands: 0
Produk
  • Comirnaty Original/omicron Ba.1
    Suspension • - • Intramuscular • Canada • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul